University of Miami, Diabetes Unit D-1 — Miami, Florida

University of Miami, Diabetes Unit D-1 is a clinical research site located in Miami, Florida, United States 33136.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

University of Miami, Diabetes Unit D-1 has participated in 1 clinical trials.

Therapeutic areas: Non-Insulin-dependent Diabetes Mellitus.

Sponsors: Procter and Gamble.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Miami, Diabetes Unit D-1?

University of Miami, Diabetes Unit D-1 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Miami, Diabetes Unit D-1 conducted?

University of Miami, Diabetes Unit D-1 has 1 clinical trials on record. Their work covers Non-Insulin-dependent Diabetes Mellitus.

Is University of Miami, Diabetes Unit D-1 accredited by Crixeo Health?

University of Miami, Diabetes Unit D-1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Miami, Diabetes Unit D-1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.